{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T18:16:51Z","timestamp":1787509011785,"version":"build-2736575974"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.prp.2025.156241","type":"journal-article","created":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T22:18:45Z","timestamp":1758579525000},"page":"156241","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Clinicopathological features of SMARCA4-deficient non-small cell lung cancer"],"prefix":"10.1016","volume":"275","author":[{"given":"Lu","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leiming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"16","key":"10.1016\/j.prp.2025.156241_bib1","doi-asserted-by":"crossref","first-page":"3073","DOI":"10.1200\/JCO.2024.42.16_suppl.3073","article-title":"A pan-cancer analysis of SMARCA4 alterations and the unique clinicogenomic characteristics associated with SMARCA4 mutation types","volume":"42","author":"Gormally","year":"2024","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.prp.2025.156241_bib2","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41576-020-0278-0","article-title":"COMPASS and SWI\/SNF complexes in development and disease","volume":"22","author":"Cenik","year":"2021","journal-title":"Nat. Rev. Genet."},{"issue":"6","key":"10.1016\/j.prp.2025.156241_bib3","doi-asserted-by":"crossref","first-page":"513","DOI":"10.3892\/ol.2023.14100","article-title":"smarca4-deficient non-small cell lung cancer with an EGFR mutation: a case report","volume":"26","author":"Lijun","year":"2023","journal-title":"Oncol. Lett."},{"issue":"5","key":"10.1016\/j.prp.2025.156241_bib4","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1053\/j.semdp.2021.06.001","article-title":"Recent updates in thoracic smarca4-deficient undifferentiated tumor","volume":"38","author":"Nambirajan","year":"2021","journal-title":"Semin. Diagn. Pathol."},{"key":"10.1016\/j.prp.2025.156241_bib5","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s00401-020-02250-7","article-title":"Atypical teratoid\/rhabdoid tumors (ATRTs) with smarca4 mutation are molecularly distinct from SMARCB1-deficient cases","volume":"141","author":"Holdhof","year":"2021","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.prp.2025.156241_bib6","doi-asserted-by":"crossref","unstructured":"Orlando K.A., Douglas A.K., Abudu A., Wang Y., Tessier-Cloutier B., Su W., Peters A., Sherman L.S., Moore R., Nguyen V., Negri G.L., Colborne S., Morin G.B., Kommoss F., Lang J.D., Hendricks W.P.D., Raupach E.A., Pirrotte P., Huntsman D.G., Trent J.M., Parker J.S., Raab J.R., Weissman B.E. Re-expression of SMARCA4\/BRG1 in Small Cell Carcinoma of Ovary, Hypercalcemic Type (SCCOHT) Promotes an Epithelial-like Gene Signature through an AP-1-Dependent Mechanism. Elife. 9 (2029) e59073.","DOI":"10.7554\/eLife.59073"},{"key":"10.1016\/j.prp.2025.156241_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.216022","article-title":"smarca4: current status and future perspectives in non-small-cell lung cancer","volume":"554","author":"Tian","year":"2023","journal-title":"Cancer Lett."},{"issue":"21","key":"10.1016\/j.prp.2025.156241_bib8","doi-asserted-by":"crossref","first-page":"5701","DOI":"10.1158\/1078-0432.CCR-20-1825","article-title":"The genomic landscape of smarca4 alterations and associations with outcomes in patients with lung cancer","volume":"26","author":"Schoenfeld","year":"2020","journal-title":"Clin. Cancer Res."},{"issue":"6","key":"10.1016\/j.prp.2025.156241_bib9","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.21037\/qims-23-1813","article-title":"SMARCA4-deficient non-small cell lung cancer: a case description and literature analysis","volume":"14","author":"Ye","year":"2024","journal-title":"Quant. Imaging Med. Surg."},{"issue":"1","key":"10.1016\/j.prp.2025.156241_bib10","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1159\/000510323","article-title":"Cytology of SMARCA4-deficient thoracic neoplasms: comparative analysis of SMARCA4-deficient non-small cell lung carcinomas and SMARCA4-deficient thoracic sarcomas","volume":"65","author":"Nambirajan","year":"2021","journal-title":"Acta Cytol."},{"issue":"13","key":"10.1016\/j.prp.2025.156241_bib11","doi-asserted-by":"crossref","first-page":"14171","DOI":"10.1002\/cam4.6083","article-title":"Clinical characteristics and prognostic analysis of SMARCA4-deficient non-small cell lung cancer","volume":"12","author":"Liang","year":"2023","journal-title":"Cancer Med."},{"issue":"3","key":"10.1016\/j.prp.2025.156241_bib12","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jtho.2021.11.003","article-title":"The 2021 WHO classification of lung tumors: impact of advances since 2015","volume":"17","author":"Nicholson","year":"2022","journal-title":"J. Thorac. Oncol."},{"issue":"1","key":"10.1016\/j.prp.2025.156241_bib13","doi-asserted-by":"crossref","first-page":"90","DOI":"10.5858\/arpa.2019-0633-OA","article-title":"SMARCA4\/BRG1\u2013deficient non\u2013small cell lung carcinomas: a case series and review of the literature","volume":"145","author":"Nambirajan","year":"2021","journal-title":"Arch. Pathol. Lab. Med."},{"issue":"6","key":"10.1016\/j.prp.2025.156241_bib14","doi-asserted-by":"crossref","first-page":"3237","DOI":"10.3390\/ijms25063237","article-title":"Treatment of thoracic SMARCA4-deficient undifferentiated tumors: where we are and where we will go","volume":"25","author":"Longo","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.prp.2025.156241_bib15","article-title":"Thoracic SMARCA4-deficient tumors: a clinicopathological analysis of 52 cases with SMARCA4-deficient non-small cell lung cancer and 20 cases with thoracic SMARCA4-deficient undifferentiated tumor","volume":"12","author":"Zhou","year":"2024","journal-title":"PeerJ"},{"issue":"1","key":"10.1016\/j.prp.2025.156241_bib16","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s12672-023-00639-w","article-title":"Thoracic SMARCA4-deficient undifferentiated tumor","volume":"14","author":"Jiang","year":"2023","journal-title":"Discov. Oncol."},{"key":"10.1016\/j.prp.2025.156241_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.lungcan.2024.108022","article-title":"Effective treatment strategies and key factors influencing therapeutic efficacy in advanced SMARCA4-deficient non-small cell lung cancer","volume":"198","author":"Liu","year":"2024","journal-title":"Lung Cancer"},{"issue":"2","key":"10.1016\/j.prp.2025.156241_bib18","first-page":"136","article-title":"Clinicopathological analysis of 42 cases of SMARCA4-deficient pulmonary adenocarcinoma. Chinese","volume":"53","author":"Han","year":"2024","journal-title":"J. Pathol."},{"issue":"5","key":"10.1016\/j.prp.2025.156241_bib19","first-page":"873","article-title":"Clinicopathological characteristics of SMARCA4-deficient non-small cell lung cancer","volume":"43","author":"Zhao","year":"2023","journal-title":"J. Clin. Pathol. Res."},{"issue":"5","key":"10.1016\/j.prp.2025.156241_bib20","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.jtho.2020.01.002","article-title":"Clinicopathologic characteristics of BRG1-deficient NSCLC","volume":"15","author":"Dagogo-Jack","year":"2020","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.prp.2025.156241_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.anndiagpath.2025.152499","article-title":"Clinical and pathological characteristics and prognostic factors of SMARCA4-deficient non-small cell lung cancer","author":"Zhang","year":"2025","journal-title":"Ann. Diagn. Pathol."},{"key":"10.1016\/j.prp.2025.156241_bib22","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2024.2340154","article-title":"Redox(high) phenotype mediated by keap1\/ stk11\/smarca4\/nrf2 mutations diminishes tissue-resident memory CD8+ t cells and attenuates the efficacy of immunotherapy in lung adenocarcinoma","volume":"13","author":"Wei","year":"2024","journal-title":"OncoImmunology"},{"issue":"12","key":"10.1016\/j.prp.2025.156241_bib23","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1002\/2211-5463.13899","article-title":"smarca4 mutations and expression in lung adenocarcinoma: prognostic significance and impact on the immunotherapy response","volume":"14","author":"Zhang","year":"2024","journal-title":"FEBS Open Bio"},{"issue":"12","key":"10.1016\/j.prp.2025.156241_bib24","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1111\/1759-7714.13215","article-title":"Exceptionally rapid response to pembrolizumab in a SMARCA4-deficient thoracic sarcoma overexpressing PD-L1: a case report","volume":"10","author":"Takada","year":"2019","journal-title":"Thorac. Cancer"},{"issue":"8","key":"10.1016\/j.prp.2025.156241_bib25","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000036959","article-title":"Efficacy of immune checkpoint inhibitors in SMARCA4-deficient and tp53 mutant undifferentiated lung cancer","volume":"103","author":"Chen","year":"2024","journal-title":"Medicine"},{"issue":"6","key":"10.1016\/j.prp.2025.156241_bib26","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.annonc.2020.02.017","article-title":"Clinicopathological and genomic correlates of programmed cell death ligand 1 (PD-L1) expression in nonsquamous non-small-cell lung cancer","volume":"31","author":"Lamberti","year":"2020","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.prp.2025.156241_bib27","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.lungcan.2020.11.006","article-title":"PDL1 high expression without tp53, keap1 and epha5 mutations could better predict survival for patients with NSCLC receiving atezolizumab","volume":"151","author":"Wang","year":"2021","journal-title":"Lung Cancer"},{"issue":"8","key":"10.1016\/j.prp.2025.156241_bib28","doi-asserted-by":"crossref","first-page":"e133","DOI":"10.1016\/j.jtho.2020.03.030","article-title":"Efficacy of immune checkpoint inhibitors in SMARCA4-mutant NSCLC","volume":"15","author":"Zhou","year":"2020","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.prp.2025.156241_bib29","doi-asserted-by":"crossref","first-page":")108644","DOI":"10.1016\/j.lungcan.2025.108644","article-title":"Acquired smarca4 alterations: an uncommon contributor to cancer progression in lung adenocarcinomas","author":"Gagn\u00e9","year":"2025","journal-title":"Lung Cancer"},{"issue":"5","key":"10.1016\/j.prp.2025.156241_bib30","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1111\/1759-7714.13070","article-title":"Successful treatment with nivolumab for SMARCA4-deficient non-small cell lung carcinoma with a high tumor mutation burden: a case report","volume":"10","author":"Naito","year":"2019","journal-title":"Thorac. Cancer"},{"issue":"1","key":"10.1016\/j.prp.2025.156241_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000546630","article-title":"Successful treatment with sintilimab for SMARCA4-deficient non-small cell lung carcinoma: two case reports. Discover","volume":"16","author":"Wang","year":"2025","journal-title":"Oncology"}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033825004340?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033825004340?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T22:41:38Z","timestamp":1762296098000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033825004340"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":31,"alternative-id":["S0344033825004340"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2025.156241","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinicopathological features of SMARCA4-deficient non-small cell lung cancer","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2025.156241","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"156241"}}